160596-25-8 (罗格列酮相关物质A,(5Z)-Rosiglitazone)

罗格列酮杂质A;硫酸茚地那韦;罗格列酮相关物质A;

Rosiglitazone Related Compound A;(5Z)-Rosiglitazone;(5Z)-5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methylidene]-1,3-thiazolidine-2,4-dione;AC-3462;(5Z)-5-{[4-({2-[Methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione;Rosiglitazone Related Compound A (25 mg) ((5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione);UNII-7JSD8Q9B3G;BDBM50049242;DTXSID101128074;5-[4-[2-[N-Methyl-N-(2-pyridinyl)amino]ethoxy]-benzylidene]-2,4-thiazolidinedione;(z)-5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]-methylene]-1,3-thiazolidine-2,4-dione;Q27268428;(5Z)-5-[[4-[2-(Methyl-2-pyridinylamino)ethoxy]phenyl]methylene]-2,4-thiazolidinedione;CHEMBL297312;(5Z)-5-((4-((2-(Methyl(2-pyridinyl)amino)ethyl)oxy)phenyl)methylidene)-1,3-thiazolidine-2,4-dione;4-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methylidene]-1,3-thiazolidine-2,5-dione;2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methylene]-;SCHEMBL2260054;122320-74-5;ROSIGLITAZONE TARTRATE IMPURITY I;7JSD8Q9B3G;5-[1-{4-[2-(Methyl-pyridin-2-yl-amino)-ethoxy]-phenyl}-meth-(Z)-ylidene]-thiazolidine-2,4-dione;AKOS025402034;2,4-Thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methylene)-, (5Z)-;Rosiglitazone Stage 3; SB-200922; USP Rosiglitazone Related Compound A;160596-25-8;Didehydro rosiglitazone, (5Z)-;(5Z)-didehydro rosiglitazone;ROSIGLITAZONETARTRATEIMPURITYI;

HCDYSWMAMRPMST-QINSGFPZSA-N

1S/C18H17N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,12H,10-11H2,1H3,(H,20,22,23)/b15-12-

S1C(NC(/C/1=C/C1C=CC(=CC=1)OCCN(C)C1C=CC=CN=1)=O)=O